Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease.

Gut Liver · 2021 · PMC8283299 · PMID 33024062

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

of borderline significancep=0.059so close (0.05 < p ≤ 0.1)

Furthermore, patients with transient ADAs to IFX also had relatively lower ADA titers of borderline significance compared with those exhibiting sustained ADAs and those who had switched to ADL due to secondary LOR (75.60±68.82 AU/mL vs 14.97±4.37 AU/mL; p=0.059).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.